Central Illinois Pediatrics is categorized under Doctors in Effingham, IL and active since 1994.
Central Illinois Pediatrics was established in 1994, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Doctors business, which does work in the B2C market, and is classified as a Doctors, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Kathy Eckstein, Office Manager at the company’s single location by writing to 900 West Temple Avenue # 203, Effingham, Illinois IL 62401 or by phoning (217) 342-5405. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Central Illinois Pediatrics |
| Contact Person: | Kathy Eckstein, Office Manager |
| Address: | 900 West Temple Avenue # 203, Effingham, Illinois 62401 |
| Phone Number: | (217) 342-5405 |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 1994 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Central Illinois Pediatrics was started in 1994 to provide professional Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Kathy Eckstein, Office Manager for inquiries that concern Central Illinois Pediatrics by calling the company number (217) 342-5405, as your correspondence is most welcome. Additionally, the physical location of the single location of Central Illinois Pediatrics can be found at the coordinates 39.12762,-88.55323 as well as the street address 900 West Temple Avenue # 203 in Effingham, Illinois 62401.
For its online presence, you may visit Central Illinois Pediatrics’s website at and engage with its social media outlets through on Twitter and on Facebook.